FIGURE

Fig. 7

ID

ZDB-FIG-250821-25

Publication

Bentanachs et al., 2025 - Telmisartan Reverses Hepatic Steatosis via PCK1 Upregulation: A Novel PPAR-independent Mechanism in Experimental Models of MASLD

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

Metabolomic analysis of liver samples from CT, HFHFr Tel groups. Principal component analysis (A) and partial least squares discriminant analysis (B) showing the clustering patterns and separation of metabolic profiles from the different groups. Volcano plots highlighting significant differences (P < 0.05, |Log₂FC| > 0.5, colored) in HFHFr vs. CT (C) and Tel vs. HFHFr (D). Pathway enrichment analysis using Over-Representation Analysis with metabolites that were significantly altered (P < 0.05, |Log₂FC| > 0.5) in the HFHFr vs. CT (E) and Tel vs. HFHFr (F) comparisons. Dot size is proportional to the number of hits per pathway.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.